fda drug safety communication naion semaglutide 2025 The NAION signal observed with semaglutide continues to generate Frontiers | Unmasking counterfeit semaglutide:

Several other innovative oral and injectable weight loss medications, including orforglipron, danuglipron, and mazdutide, are in development or clinical trials, offering various mechanisms and promising results for weight loss and diabetes management

people in under-resourced communities experience higher rates of hypertension, ischemic heart disease, and heart failure, partly due to barriers in accessing preventive care

operations and global business development and president of Novo Nordisk, said in a statement

You are well within the safe range

Any weight loss associated with yerba mate is likely attributable to increased calorie expenditure and appetite suppression via central nervous system stimulation, not hormonal GLP-1 pathways

Interested in long-term healthy aging